Epilepsia · 2000 · 162 citations · 16 references
MedicineNeurologyPharmacotherapyEpilepsyPediatric Clinical PharmacologyPediatric PharmacotherapyAntiepileptic PharmacotherapyElectroencephalography In EpilepsyEpilepsy In ChildhoodSeizure ManagementAdverse Drug EventsElectroencephalography In Childhood EpilepsyMonotherapy Of EpilepsyNeurological Adverse EventsPediatric Epilepsy PharmacotherapyPlacebo ComparatorsSeizuresTreatment Outcomes In Epilepsy
PURPOSE: To evaluate the efficacy and tolerability of sulthiame (STM) as monotherapy in children with benign childhood epilepsy with centrotemporal spikes (BECTS). METHODS: Sixty-six BECTS patients entered a 6-month double-blind trial and were randomized to receive either STM (5 mg/kg/day) or a placebo. All patients had had two or more seizures during the 6 months preceding the trial and were aged 3-11 years. Seizures were recorded by parents in a diary. STM plasma levels and electroencephalograms (EEGs) were overseen by patient-blinded observers. The primary effectiveness variable was the rate of treatment failure events (TFEs) per group. TFEs consisted of a first seizure after a 7-day run-in period, intolerable adverse events (AEs), development of another epileptic syndrome, or termination of the trial by parents or patient. RESULTS: Twenty-five of the 31 STM-treated patients (81%) and 10 of the 35 placebo-treated patients (29%) completed the trial without any TFEs (p = 0.00002). Most TFEs were seizures (n = 4 for the STM patients, n = 21 for the placebo group). Parents requested termination for two placebo-treated patients. Four patients were terminated for administrative reasons. No patient was withdrawn for AEs. While all patients displayed at least one specific focus in either the awake or asleep EEG initially, 11 STM-treated patients had a normal awake EEG and 10 had a normal asleep one after 6 months. CONCLUSIONS: STM was remarkably effective in preventing seizures in patients with BECTS. Patients suffering from > or = 2 seizures during the past 6 months had a high risk of early recidivism. STM was well tolerated and should be considered for children with BECTS who are in need of treatment.
16
Proposal for Revised Classification of Epilepsies and Epileptic Syndromes
Epilepsia · 1989 · 5.4K citations
Medicine, Neurology, Neuroscience +12
Epileptic Syndromes in Infancy, Childhood and Adolescence
J. Rogers, M. Bureau, C. Dravet et al. · Journal of Neuropathology & Experimental Neurology · 1993 · 1.5K citations · Full text
Medicine, Neuroscience, Pediatrics +12
Evaluation of Experiments with Adaptive Interim Analyses
Péter Bauer, Karl Kohne · Biometrics · 1994 · 873 citations
Epilepsy: A Comprehensive Textbook
Robert A. Gross · Archives of Neurology · 1998 · 457 citations